TF and lung cancer: Survival analysis performed in this study revealed that higher body iron content (mainly expressed by higher iron level and transferrin saturation) detected prior to treatment may be associated with decreased risk of death among lung cancer patients (S6 Table and S1 Fig and S5 Fig).